The Presence of Ascending Aortic Dilatation in Patients Undergoing Transcatheter Aortic Valve Replacement Is Negatively Correlated with the Presence of Diabetes Mellitus and Does Not Impair Post-Procedural Outcomes.
Elke BoxhammerStefan HechtReinhard KaufmannJürgen KammlerJörg KellermairChristian ReiterKaveh AkbariHermann BlessbergerClemens SteinwenderMichael LichtenauerUta C HoppeKlaus HerganBernhard ScharingerPublished in: Diagnostics (Basel, Switzerland) (2023)
The presence of AA dilatation before successful TAVR was not associated with a survival disadvantage at the respective follow-up intervals of 1, 3 and 5 years. Diabetes mellitus in general seemed to have a protective effect against the development of AA dilatation or aneurysm in patients with severe AS.
Keyphrases
- transcatheter aortic valve replacement
- aortic valve
- aortic stenosis
- patients undergoing
- pulmonary artery
- coronary artery
- glycemic control
- aortic dissection
- early onset
- ejection fraction
- coronary artery disease
- pulmonary hypertension
- metabolic syndrome
- insulin resistance
- skeletal muscle
- pulmonary arterial hypertension